Ramsay Generale de Sante : Générale de Santé publishes offer document and updates the timetable in its public offer to the shareholders of Capio

	COMMUNIQUÉ DE PRESSE
THIS PRESS RELEASE MAY NOT, DIRECTLY OR INDIRECTLY, BE DISTRIBUTED OR PUBLISHED IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, OR SOUTH AFRICA. THE OFFER IS NOT BEING MADE TO (AND ACCEPTANCES WILL NOT BE APPROVED FROM) PERSONS IN THOSE JURISDICTIONS OR ANY OTHER JURISDICTION WHERE SUCH PERSONS' ACCEPTANCE OF THE OFFER REQUIRES FURTHER OFFER DOCUMENTS, FILINGS OR OTHER MEASURES IN ADDITION TO THOSE REQUIRED UNDER SWEDISH LAW.   Ramsay Générale de Santé publishes offer document and updates the timetable in its public offer to the shareholders of Capio
Paris, 5 September 2018 - On 13 July 2018, Ramsay Générale de Santé S.A. ("RGdS") announced a public offer to acquire all shares in Capio AB (publ) ("Capio") for SEK 48.5 in cash per share (the "Offer"). The offer document that has been prepared in connection with the Offer was approved and registered by the Swedish Financial Supervisory Authority (the "SFSA") today on 5 September 2018 (the "Offer Document"). The Offer Document and the acceptance form are now available on RGdS' website (www.ramsaygds.se) and Handelsbanken's website (www.handelsbanken.se/ investeringserbjudande) and will be distributed to shareholders whose shares were directly registered with Euroclear Sweden AB on 5 September 2018.     Updated timetable   The acceptance period in the Offer commences on 6 September 2018 and expires on 25 October 2018. Settlement is expected to commence on or around 7 November 2018. RGdS reserves the right to extend the acceptance period as well as to postpone the settlement date. Any extensions of the acceptance period or postponements of the settlement date will be announced by a press release in accordance with applicable laws and regulations (including Nasdaq Stockholm's Takeover Rules).   The completion of the Offer is conditional upon, among other things, approvals from relevant competition authorities. As the processes with the European Commission and the French Competition Authority have been proceeding faster than expected, RGdS has decided to revise the timetable and set the acceptance period to 6 September-25 October 2018.   Further information   This press release was submitted for publication on 5 September 2018 at 17.45 CET.   For more information about the Offer, please visit: www.ramsaygds.se   For further information about RGdS, please contact: Caroline DESAEGHER | Communication Director Mobile : [phone] Landline: [phone] [e-mail]   or visit www.ramsaygds.fr   Ramsay Générale de Santé S.A. is listed on the regulated market of Euronext in Paris and is included in the Midcac index. Ramsay Générale de Santé is a leading Group in the private healthcare sector in France with 23,000 employees in 120 private clinics. The Group works with 6,000 practitioners, forming a leading independent medical community in France. A major player in hospitalisation, Ramsay Générale de Santé provides a comprehensive range of patient care services in three business segments: Medicine-Surgery-Obstetrics, sub-acute care and rehabilitation, and mental health. Ramsay Générale de Santé has developed a unique healthcare service, built around the quality and security of patient care and organisational efficiency. The Group takes a comprehensive approach to patient care, including personalised assistance and support before, during and after hospitalisation. Ramsay Générale de Santé also participates in public service missions in its sector and helps to strengthen France's mainland healthcare network.   Important information   The Offer is not being made to, and acceptances will not be approved from, persons whose participation in the Offer requires that an additional offer document is prepared or registration effected or that any other measures are taken in addition to those required under Swedish law (including Nasdaq Stockholm's Takeover Rules), except where there is an applicable exemption.   This press release, the Offer Document, the acceptance form and any documentation related to the Offer (including copies thereof) must not be mailed or otherwise distributed, forwarded or sent in or into any jurisdiction (including without limitation Australia, Canada, Hong Kong, Japan, New Zealand or South Africa) in which the distribution of such documentation or the Offer would require any additional measures to be taken or would be in conflict with any law or regulation in any such jurisdiction. Persons who receive this press release, the Offer Document or the acceptance form (including without limitation banks, brokers, dealers, nominees, trustees and custodians) and are subject to the laws or regulations of any such jurisdiction will need to inform themselves about, and observe, any applicable restrictions or requirements. Any failure to do so may constitute a violation of the securities laws or regulations of any such jurisdiction. To the extent permitted by applicable law, RGdS disclaims any responsibility or liability for any violations of any such restrictions by any person and RGdS reserves the right to disregard any purported acceptance of the Offer resulting directly or indirectly from a violation of any of these restrictions.   Statements in this press release relating to future status or circumstances, including statements regarding future performance, growth and other trend projections and the other benefits of the Offer, are forward-looking statements. These statements may generally, but not always, be identified by the use of words such as "anticipate", "believe", "expect", "intend", "plan", "seek", "will", "would" or similar expressions. By their nature, forward-looking statements involve risk and uncertainty because they relate to events and depend on circumstances that could occur in the future. There can be no assurance that actual results will not differ materially from those expressed or implied by these forward-looking statements due to many factors, many of which are outside RGdS' control. Any such forward-looking statements speak only as of the date on which they are made and RGdS has no obligation (and undertakes no such obligation) to update or revise any of them, whether as a result of new information, future events or otherwise.   This press release has been published in English, French and Swedish. In the event of any discrepancy between the three language versions, the English version shall prevail.   Information for U.S. securityholders   The Offer described in this press release and the Offer Document is made for the securities of Capio and is subject to the laws of Sweden. It is important that U.S. holders understand that the Offer, this press release and the Offer Document are subject to disclosure and takeover laws and regulations in Sweden that may be different from those in the United States. To the extent applicable, RGdS will comply with Regulation 14E under the U.S. Securities Exchange Act of 1934, as amended (the "Exchange Act").   RGdS intends to treat the Offer as one to which the "Tier II" exemption mentioned in Rule 14d-1(d) under the Exchange Act applies. Pursuant to an exemption from Rule 14e-5 under the Exchange Act, RGdS may, from time to time, purchase or make arrangements to purchase shares outside the Offer from the time the Offer was announced until the expiration of the acceptance period of the Offer, including purchases in the open market at prevailing prices or in private transactions at negotiated prices and to the extent permitted under the applicable Swedish laws and regulations and provided certain other conditions are met. Any change in RGdS' shareholding in Capio which entails that RGdS' holding of shares or votes in Capio reaches, exceeds or falls below any of the limits of 5, 10, 15, 20, 25, 30, 50, 662/3 or 90 per cent will be reported in writing by RGdS to Capio and the SFSA in accordance with Chapter 4 of the Swedish Financial Instruments Trading Act. The SFSA will publish the information not later than noon on the trading day following the day on which the SFSA received the report. Such information regarding purchases of shares in Capio outside of the Offer will also be disclosed in the United States.   Neither the U.S. Securities and Exchange Commission nor any securities commission of any state of the United States has (a) approved or disapproved the Offer, (b) passed upon the merits or fairness of the Offer, or (c) passed upon the adequacy or accuracy of the disclosure in this press release or the Offer Document. Any representation to the contrary is a criminal offence in the United States.
About Ramsay Générale de Santé Ramsay Générale de Santé S.A. is listed on the regulated market of Euronext in Paris and is included in the Midcac index. Ramsay Générale de Santé is a leading Group in the private healthcare sector in France with 23,000 employees in 120 private clinics. The Group works with 6,000 practitioners, forming a leading independent medical community in France. A major player in hospitalisation, Ramsay Générale de Santé provides a comprehensive range of patient care services in three business segments: Medicine-Surgery-Obstetrics, sub-acute care and rehabilitation, and mental health. Ramsay Générale de Santé has developed a unique healthcare service, built around the quality and security of patient care and organisational efficiency. The Group takes a comprehensive approach to patient care, including personalised assistance and support before, during and after hospitalisation. Ramsay Générale de Santé also participates in public service missions in its sector and helps to strengthen France's mainland healthcare network. Site Internet: www.ramsaygds.fr Facebook: https://www.facebook.com/RamsayGDS Twitter: https://twitter.com/RamsayGDS LinkedIn: https://www.linkedin.com/company/ramsaygds YouTube: https://www.youtube.com/channel/UCpSNsGhH-xc84K6Fv7XxKPw     Press Contact   Ramsay Générale de Santé : Caroline Desaegher - 06 03 79 07 78-  [e-mail]

Ramsay Générale de Santé publishes offer document

---

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: RAMSAY GENERALE DE SANTE via Globenewswire